SHA:600062 Market Cap

SHA:600062 has a market cap or net worth of 17.26 billion as of June 9, 2026. Its market cap has decreased by -10.58% in one year.

Market Cap

17.26B

Enterprise Value

16.76B

Revenue

10.73B

Ranking

n/a

PE Ratio

10.65

Stock Price

16.71

Market Cap Chart

Since March 1, 2004, SHA:600062's market cap has increased from 9.40B to 17.26B, an increase of 83.52%. That is a compound annual growth rate of 2.76%.

Market Cap History

Date	Market Cap	% Change
Jun 8, 2026	17.26B	-8.62%
Dec 31, 2025	18.89B	-7.08%
Dec 31, 2024	20.32B	5.43%
Dec 29, 2023	19.28B	5.47%
Dec 30, 2022	18.28B	31.03%
Dec 31, 2021	13.95B	11.51%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Jilin Aodong Pharmaceutical Group	19.37B
Chengdu Kanghong Pharmaceutical Group	18.54B
Guangdong Zhongsheng Pharmaceutical	18.54B
Walvax Biotechnology	18.31B
Hybio Pharmaceutical	18.18B
Apeloa Pharmaceutical Co.,Ltd	17.85B
Dizal (Jiangsu) Pharmaceutical	17.56B
Joincare Pharmaceutical Group Industry	17.22B

Market Cap Rankings